La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Sejong Medical Gestione
Gestione criteri di controllo 0/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Byungsung Kim
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 1.4yrs |
| Proprietà del CEO | n/a |
| Durata media del management | Nessun dato |
| Durata media del Consiglio di amministrazione | Nessun dato |
Aggiornamenti recenti sulla gestione
Nessun aggiornamento
Recent updates
Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively
Mar 24
Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year
Mar 02Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?
Feb 11We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability
Jan 27Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?
Jan 12Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon
Dec 25Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?
Dec 23
These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well
Dec 08The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More
Nov 19AMMINISTRATORE DELEGATO
Byungsung Kim (54 yo)
1.4yrs
Mandato
Byungsung Kim serves as Chief Executive Officer at Sejong Medical Co., Ltd. since 2023. Byungsung Kim served as Representative Director at Sejong Medical Co., Ltd.